Terms: = Breast cancer AND VHL, HRCA1, P40337, 7428, ENSG00000134086, RCA1, VHL1 AND Prognosis
21 results:
1. Discovery of ganoderic acid A (GAA) PROTACs as MDM2 protein degraders for the treatment of breast cancer.
Li Y; Li G; Zuo C; Wang X; Han F; Jia Y; Shang H; Tian Y
Eur J Med Chem; 2024 Apr; 270():116367. PubMed ID: 38581732
[TBL] [Abstract] [Full Text] [Related]
2. vhl suppresses autophagy and tumor growth through PHD1-dependent Beclin1 hydroxylation.
Wang Z; Yan M; Ye L; Zhou Q; Duan Y; Jiang H; Wang L; Ouyang Y; Zhang H; Shen Y; Ji G; Chen X; Tian Q; Xiao L; Wu Q; Meng Y; Liu G; Ma L; Lei B; Lu Z; Xu D
EMBO J; 2024 Mar; 43(6):931-955. PubMed ID: 38360997
[TBL] [Abstract] [Full Text] [Related]
3. Genetic mutations in HER2-positive breast cancer: possible association with response to trastuzumab therapy.
Zakaria NH; Hashad D; Saied MH; Hegazy N; Elkayal A; Tayae E
Hum Genomics; 2023 May; 17(1):43. PubMed ID: 37202799
[TBL] [Abstract] [Full Text] [Related]
4. Health education actions on male breast cancer: A protocol for systematic review and meta analysis.
Silva JFCD; Torres GV; Reis LAD; Campos JTAM; Nunes VMA; Santos JCC; Barbalho TNS; Xavier Nobre TT
Medicine (Baltimore); 2022 Oct; 101(42):e30931. PubMed ID: 36281187
[TBL] [Abstract] [Full Text] [Related]
5. TET2 Suppresses vhl Deficiency-Driven Clear Cell Renal Cell Carcinoma by Inhibiting HIF Signaling.
Zhang X; Li S; He J; Jin Y; Zhang R; Dong W; Lin M; Yang Y; Tian T; Zhou Y; Xu Y; Lei QY; Zhang J; Zhang Q; Xu Y; Lv L
Cancer Res; 2022 Jun; 82(11):2097-2109. PubMed ID: 35176127
[TBL] [Abstract] [Full Text] [Related]
6. TARBP2 Suppresses Ubiquitin-Proteasomal Degradation of HIF-1α in breast cancer.
Li JN; Chen PS; Chiu CF; Lyu YJ; Lo C; Tsai LW; Wang MY
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008634
[TBL] [Abstract] [Full Text] [Related]
7. Quantitative Longitudinal Imaging Reveals that Inhibiting Hedgehog Activity Alleviates the Hypoxic Tumor Landscape.
Lama-Sherpa TD; Das S; Hinshaw DC; Kammerud SC; Song PN; Alsheikh HA; Sorace AG; Samant RS; Shevde LA
Mol Cancer Res; 2022 Jan; 20(1):150-160. PubMed ID: 34593607
[TBL] [Abstract] [Full Text] [Related]
8. Bilateral breast Radiation Associated Angiosarcoma After Radiotherapy for Bilateral Invasive Ductal Adenocarcinoma.
Vin Chang G; Xie C; Shahid M; Draine J; Alpers J; Reindl B; McHale M
S D Med; 2021 Jun; 74(6):260-263. PubMed ID: 34449165
[TBL] [Abstract] [Full Text] [Related]
9. Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade.
Terry S; Dalban C; Rioux-Leclercq N; Adam J; Meylan M; Buart S; Bougoüin A; Lespagnol A; Dugay F; Moreno IC; Lacroix G; Lorens JB; Gausdal G; Fridman WH; Mami-Chouaib F; Chaput N; Beuselinck B; Chabaud S; Barros-Monteiro J; Vano Y; Escudier B; Sautès-Fridman C; Albiges L; Chouaib S
Clin Cancer Res; 2021 Dec; 27(24):6749-6760. PubMed ID: 34407968
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic Value of Melanoma-Associated Antigen-A (MAGE-A) Gene Expression in Various Human cancers: A Systematic Review and Meta-analysis of 7428 Patients and 44 Studies.
Poojary M; Jishnu PV; Kabekkodu SP
Mol Diagn Ther; 2020 Oct; 24(5):537-555. PubMed ID: 32548799
[TBL] [Abstract] [Full Text] [Related]
11. Polymorphisms in GSTT1 and GSTM1 genes as possible risk factors for susceptibility to breast cancer development and their influence in chemotherapy response: a systematic review.
Pacholak LM; Amarante MK; Guembarovski RL; Watanabe MAE; Panis C
Mol Biol Rep; 2020 Jul; 47(7):5495-5501. PubMed ID: 32494978
[TBL] [Abstract] [Full Text] [Related]
12. Regulation of KLF4 by posttranslational modification circuitry in endocrine resistance.
Zhou Z; Song X; Chi JJ; Gius DR; Huang Y; Cristofanilli M; Wan Y
Cell Signal; 2020 Jun; 70():109574. PubMed ID: 32084531
[TBL] [Abstract] [Full Text] [Related]
13. Theranostic application of
Cava C; Novello C; Martelli C; Lodico A; Ottobrini L; Piccotti F; Truffi M; Corsi F; Bertoli G; Castiglioni I
Theranostics; 2020; 10(1):50-61. PubMed ID: 31903105
[TBL] [Abstract] [Full Text] [Related]
14. Diallyl trisulfides, a natural histone deacetylase inhibitor, attenuate HIF-1α synthesis, and decreases breast cancer metastasis.
Wei Z; Shan Y; Tao L; Liu Y; Zhu Z; Liu Z; Wu Y; Chen W; Wang A; Lu Y
Mol Carcinog; 2017 Oct; 56(10):2317-2331. PubMed ID: 28574600
[TBL] [Abstract] [Full Text] [Related]
15. Predicting cancer-specific vulnerability via data-driven detection of synthetic lethality.
Jerby-Arnon L; Pfetzer N; Waldman YY; McGarry L; James D; Shanks E; Seashore-Ludlow B; Weinstock A; Geiger T; Clemons PA; Gottlieb E; Ruppin E
Cell; 2014 Aug; 158(5):1199-1209. PubMed ID: 25171417
[TBL] [Abstract] [Full Text] [Related]
16. miR-21-3p is a positive regulator of L1CAM in several human carcinomas.
Doberstein K; Bretz NP; Schirmer U; Fiegl H; Blaheta R; Breunig C; Müller-Holzner E; Reimer D; Zeimet AG; Altevogt P
Cancer Lett; 2014 Nov; 354(2):455-66. PubMed ID: 25149066
[TBL] [Abstract] [Full Text] [Related]
17. Proline-hydroxylated hypoxia-inducible factor 1α (HIF-1α) upregulation in human tumours.
Snell CE; Turley H; McIntyre A; Li D; Masiero M; Schofield CJ; Gatter KC; Harris AL; Pezzella F
PLoS One; 2014; 9(2):e88955. PubMed ID: 24563687
[TBL] [Abstract] [Full Text] [Related]
18. Upregulation of miRNA-155 promotes tumour angiogenesis by targeting vhl and is associated with poor prognosis and triple-negative breast cancer.
Kong W; He L; Richards EJ; Challa S; Xu CX; Permuth-Wey J; Lancaster JM; Coppola D; Sellers TA; Djeu JY; Cheng JQ
Oncogene; 2014 Feb; 33(6):679-89. PubMed ID: 23353819
[TBL] [Abstract] [Full Text] [Related]
19. [Structural and functional analysis of tumor genomes and the development of test systems for early diagnosis, prognosis and cancer therapy optimization].
Zaletaev DV; Strel'nikov VV; Nemtsova MV; Babenko OV; Kuznetsova EB; Zemliakova VV; Kekeeva TV; Mikhaĭlenko DS; Tanas AS; Rudenko VV; Babaian AIu; Alekseeva EA; Simonova OA
Vestn Ross Akad Med Nauk; 2013; (9):7-14. PubMed ID: 24624866
[TBL] [Abstract] [Full Text] [Related]
20. Hypoxia-inducible factor 1 is activated by dysregulated cyclin E during mammary epithelial morphogenesis.
Sengupta T; Abraham G; Xu Y; Clurman BE; Minella AC
Mol Cell Biol; 2011 Sep; 31(18):3885-95. PubMed ID: 21746877
[TBL] [Abstract] [Full Text] [Related]
[Next]
